| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Bausch + Lomb Corporation's insiders have reduced their positions by a net 170,974 shares worth roughly $3.3M. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.26M | $25.16M | - | |
| CFO | 393.5K | $7.88M | - | |
| VP | 264.2K | $5.29M | - | |
| VP | 187.3K | $3.75M | - | |
| Pres | 103.8K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Russel C Robertson | Director | Buy | 4,400 | $17.90 | $78,760.00 | +6.5% | -10.0% | - | |
| Feb 19, 2026 | Karen Ling | Director | Buy | 4,000 | $17.74 | $70,968.00 | +10.6% | -8.2% | - | |
| May 22, 2025 | Brent L Saunders52 | CEO and Chairman of the Board | Buy | 22,000 | $11.28 | $248,072.00 | +3.2% | +29.2% | +41.5% | |
| May 2, 2025 | Andrew C. Von Eschenbach46 | Director | Buy | 1,695 | $11.76 | $19,924.73 | +4.2% | +18.5% | +41.8% | |
| Aug 5, 2024 | Brent L Saunders52 | CEO and Chairman of the Board | Buy | 32,250 | $15.66 | $505,067.25 | +5.7% | +29.0% | -6.2% | |
| Jun 1, 2022 | Bausch Health Companies Inc. | 10% Owner | Sell | 4,550,357 | $17.06 | $77,606,338.64 | -1.4% | -10.6% | +12.1% | |
| May 10, 2022 | Bausch Health Companies Inc. | 10% Owner | Sell | 35,000,000 | $17.06 | $596,925,000.00 | -10.0% | -11.7% | +4.6% |